Controlled Release Bone Morphogenic Protein/Nano-calcium

Award Information
Agency:
Department of Health and Human Services
Branch
n/a
Amount:
$156,878.00
Award Year:
2005
Program:
SBIR
Phase:
Phase I
Contract:
1R43DE017468-01
Agency Tracking Number:
DE017468
Solicitation Year:
2005
Solicitation Topic Code:
n/a
Solicitation Number:
PHS2005-2
Small Business Information
SPIRE CORPORATION
Spire Corporation, 1 Patriots Park, Bedford, MA, 01730
Hubzone Owned:
N
Socially and Economically Disadvantaged:
N
Woman Owned:
N
Duns:
n/a
Principal Investigator:
MARISA SAMBITO
(781) 275-6000
MSAMBITO@SPIRECORP.COM
Business Contact:
MARK LITTLE
(781) 275-6000
MLITTLE@SPIRECORP.COM
Research Institution:
n/a
Abstract
DESCRIPTION (provided by applicant): Controlled Release of Bone Morphogenic Protein using Nano-Calcium Phosphate Coatings TP-2004-71 We propose a novel method for depositing a drug-loaded coating based on a mixture of nano-phase calcium phosphate and bone morphogenic protein (BMP) on metal implants. One unique feature of the coating is that it will release the drug in a controlled fashion following the surgical procedure. Additionally, the coating is made up of nano-sized calcium phosphate features, which we have shown in preliminary studies to significantly enhance osteoblast function. In Phase I feasibility studies, three nano-calcium phosphate coating formulations (amorphous, semi- crystalline and crystalline) will be synthesized at Purdue University. Nano-phase calcium phosphate will then be mixed with BMP and coated onto titanium substrates using our novel deposition process. The coating on these samples will be evaluated for rate of release with the goal of reproducing our successful previous results from pelletized form of nano-CaPCVBMP material. After controlled rate of release has been demonstrated, we will assess protein bioactivity in vitro using osteoblast reactivity assay on nano-calcium phosphate material with and without BMP. Various structural and material characteristics of the coated samples will be studied using SEM, XRD, AFM and EDS. In Phase II, nano-CaPCVBMP coatings on implants will be evaluated in an in vivo animal model.

* information listed above is at the time of submission.

Agency Micro-sites

US Flag An Official Website of the United States Government